Moderna, Inc. against Teva Pharmaceutical Industries Limited — live side-by-side technical comparison.
Prices as of 2026-09-23T20:00:01+00:00 UTC · updates daily
MRNA leads 5 of the 5 windows we measure — over 1 month MRNA is +31.1% and TEVA +5.6%; over year to date MRNA is +517.5% and TEVA +25.0%. The MRNA/TEVA price ratio stands at 4.6683, above its 50-day average of 2.8727, and above the 200-day average of 1.8372. A ratio above its own average means MRNA is gaining on TEVA; on this reading the recent edge belongs to MRNA.
| MRNA | TEVA | |
|---|---|---|
| Price | $182.11 | $39.01 |
| 1 day | -0.2%lead | -1.3% |
| 5 days | +25.1%lead | +1.2% |
| 1 month | +31.1%lead | +5.6% |
| 6 months | +255.1%lead | +35.6% |
| Year to date | +517.5%lead | +25.0% |
| 52-week position | 94% of range | 92% of range |
| 52-week range | $22.28–$192.31 | $18.21–$40.79 |
| vs 50-day average | above $104.86 | above $35.79 |
| vs 200-day average | above $62.57 | above $33.32 |
| RSI (14) | 70 | 59 |
| Next earnings | 2026-11-05 | 2026-11-03 |
MRNA trades at $182.11, above its 50-day average of $104.86, and above the 200-day at $62.57. It sits at 94% of its 52-week range ($22.28–$192.31); 14-day RSI is 70, in overbought territory; an average session moves it about 6.3%. For levels, the first level overhead is $182.56 (0.2% away) and the first support below is $175.00 (3.9% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
TEVA trades at $39.01, above its 50-day average of $35.79, and above the 200-day at $33.32. It sits at 92% of its 52-week range ($18.21–$40.79); 14-day RSI is 59, in neutral territory; an average session moves it about 3.3%. For levels, the first level overhead is $40.00 (2.5% away) and the first support below is $35.79 (8.2% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
MRNA is the more volatile of the two — an average session moves it 6.3% against 3.3% for TEVA, so an identical position size carries roughly 1.9× the daily risk.
The comparison turns on those levels: MRNA clearing $182.56 or losing $175.00; TEVA clearing $40.00 or losing $35.79. Until one of them gives way, the relative reading above stands.